(S)-3-((S)-2-Acetylamino-3-methyl-butyrylamino)-N-{(S)-1-[(2S,3S)-2-((S)-2-hydroxy-5-oxo-tetrahydro-furan-3-ylcarbamoyl)-3-isobutoxy-pyrrolidine-1-carbonyl]-2-methyl-propyl}-succinamic acid

ID: ALA1835314

PubChem CID: 56666820

Max Phase: Preclinical

Molecular Formula: C29H47N5O11

Molecular Weight: 641.72

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Bioactivity Summary Target Summary Assay Summary

Names and Identifiers

Canonical SMILES: CC(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N1CC[C@H](OCC(C)C)[C@H]1C(=O)N[C@H]1CC(=O)OC1O)C(C)C)C(C)C

Standard InChI: InChI=1S/C29H47N5O11/c1-13(2)12-44-19-8-9-34(24(19)27(41)32-18-11-21(38)45-29(18)43)28(42)23(15(5)6)33-25(39)17(10-20(36)37)31-26(40)22(14(3)4)30-16(7)35/h13-15,17-19,22-24,29,43H,8-12H2,1-7H3,(H,30,35)(H,31,40)(H,32,41)(H,33,39)(H,36,37)/t17-,18-,19-,22-,23-,24-,29?/m0/s1

Standard InChI Key: CKSRGYVELZYFSD-MYZDDSFLSA-N

Molfile:

     RDKit          2D

 45 46  0  0  0  0  0  0  0  0999 V2000
    3.1764  -11.6285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5027  -12.1047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7469  -12.8935    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5730  -12.9075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8373  -12.1247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0506  -13.5800    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7254  -11.8413    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1925  -10.8039    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4401  -10.4601    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7792   -9.1474    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4445   -9.6351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1152   -9.1545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8631   -8.3664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0391   -8.3658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3624   -9.1474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6507   -8.7350    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0794   -8.7350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3624   -9.9724    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9349   -9.1474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2191   -8.7350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9349   -9.9724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6507  -10.3849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2191  -10.3849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5074   -9.1474    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2191   -7.9100    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7916   -8.7350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0757   -9.1474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7916   -7.9100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0757   -9.9724    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0757   -7.4975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3592   -7.9111    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0749   -6.6737    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3641   -8.7350    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3517   -9.1474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0633   -8.7350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3517   -9.9724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3641  -10.3849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0633  -10.3849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0633   -7.9100    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7449  -10.9041    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8965   -9.4087    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6021   -8.9813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3251   -9.3788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0306   -8.9514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3423  -10.2036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 11  9  1  1
  1  5  1  0
  4  6  2  0
  2  7  1  0
  1  8  1  1
  9  8  1  0
 10 11  1  0
  1  2  1  0
  2  3  1  0
 15 16  1  0
 15 17  1  0
 15 18  2  0
 16 19  1  0
 19 20  1  0
 19 21  1  6
 21 22  1  0
 21 23  1  0
 20 24  1  0
 20 25  2  0
 24 26  1  0
 26 27  1  0
 26 28  1  1
 27 29  2  0
 28 30  1  0
 30 31  1  0
 30 32  2  0
 27 33  1  0
 33 34  1  0
 34 35  1  0
 34 36  1  6
 36 37  1  0
 36 38  1  0
 35 10  1  0
 35 39  2  0
  3  4  1  0
  9 40  2  0
  4  5  1  0
 12 41  1  6
 11 12  1  0
 41 42  1  0
 12 13  1  0
 42 43  1  0
 13 14  1  0
 43 44  1  0
 14 10  1  0
 43 45  1  0
M  END

Associated Targets(Human)

CASP2 Tchem Caspase-2 (173 Activities)

Discover Target: CASP2

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

CASP3 Tchem Caspase-3 (3632 Activities)

Discover Target: CASP3

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Natural Product: No	Oral: No	Chemical Probe: No	Parenteral: No
Molecule Type: Small molecule	Topical: No	First In Class: No	Black Box: No
Chirality: No	Availability: No	Prodrug: No

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 641.72	Molecular Weight (Monoisotopic): 641.3272	AlogP: -1.36	#Rotatable Bonds: 15
Polar Surface Area: 229.77	Molecular Species: ACID	HBA: 10	HBD: 6
#RO5 Violations: 2	HBA (Lipinski): 16	HBD (Lipinski): 6	#RO5 Violations (Lipinski): 3
CX Acidic pKa: 4.26	CX Basic pKa: ┄	CX LogP: -1.42	CX LogD: -4.42
Aromatic Rings: ┄	Heavy Atoms: 45	QED Weighted: 0.11	Np Likeness Score: 0.37

References

1. Maillard MC, Brookfield FA, Courtney SM, Eustache FM, Gemkow MJ, Handel RK, Johnson LC, Johnson PD, Kerry MA, Krieger F, Meniconi M, Muñoz-Sanjuán I, Palfrey JJ, Park H, Schaertl S, Taylor MG, Weddell D, Dominguez C.. (2011) Exploiting differences in caspase-2 and -3 S₂ subsites for selectivity: structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors., 19 (19): [PMID:21903398] [10.1016/j.bmc.2011.08.020]
2. Chen, Yi-Hua YH and 9 more authors. 2006-03-09 Design, synthesis, and biological evaluation of isoquinoline-1,3,4-trione derivatives as potent caspase-3 inhibitors. [PMID:16509578]
3. Maillard, Michel C MC and 17 more authors. 2011-10-01 Exploiting differences in caspase-2 and -3 S₂ subsites for selectivity: structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors. [PMID:21903398]

(S)-3-((S)-2-Acetylamino-3-methyl-butyrylamino)-N-{(S)-1-[(2S,3S)-2-((S)-2-hydroxy-5-oxo-tetrahydro-furan-3-ylcarbamoyl)-3-isobutoxy-pyrrolidine-1-carbonyl]-2-methyl-propyl}-succinamic acid

Names and Identifiers

Alternative Forms

Associated Targets(Human)

Molecule Features

Drug Indications

Mechanisms of Action

Biocomponents

Calculated Properties

References

Source